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Background: Samsoeum (SSE), a traditional herbal formula, has been widely used to treat cough, fever, congestion,
and emesis for centuries. Recent studies have demonstrated that SSE retains potent pharmacological efficiency in
anti-allergic and anti-inflammatory reactions. However, the anti-cancer activity of SSE and its underlying mechanisms
have not been studied. Thus, the present study was designed to determine the effect of SSE on cell death and
elucidate its detailed mechanism.
Methods: Following SSE treatment, cell growth and cell death were measured using an MTT assay and trypan blue
exclusion assay, respectively. Cell cycle arrest and YO-PRO-1 uptake were assayed using flow cytometry, and LC3
redistribution was observed using confocal microscope. The mechanisms of anti-cancer effect of SSE were investigated
through western blot analysis.
Results: We initially found that SSE caused dose- and time-dependent cell death in cancer cells but not in normal
primary hepatocytes. In addition, during early SSE treatment (6–12 h), cells were arrested in G2/M phase concomitant with
up-regulation of p21 and p27 and down-regulation of cyclin D1 and cyclin B1, followed by an increase in apoptotic
YO-PRO-1 (+) cells. SSE also induced autophagy via up-regulation of Beclin-1 expression, conversion of
microtubule-associated protein light chain 3 (LC3) I to LC3-II, and re-distribution of LC3, indicating
autophagosome formation. Moreover, the level of B-cell lymphoma 2 (Bcl-2), which is critical for cross-talk
between apoptosis and autophagy, was significantly reduced in SSE-treated cells. Phosphorylation of adenosine
monophosphate-activated protein kinase (AMPK) was increased, followed by suppression of the protein kinase
B/mammalian target of rapamycin (Akt/mTOR) pathway, and phosphorylation of mitogen-activated protein kinases
(MAPKs) in response to SSE treatment. In particular, among MAPKs inhibitors, only the c-Jun N-terminal kinase
(JNK)-specific inhibitor SP600125 nearly blocked SSE-induced increases in Beclin-1, LC3-II, and Bax expression and
decreases in Bcl-2 expression, indicating that JNK activation plays critical role in cell death caused by SSE.
Conclusions: These findings suggest that SSE efficiently induces cancer cell death via apoptosis as well as autophagy
through modification of the Akt/mTOR and JNK signaling pathways. SSE may be as a potent traditional herbal
medicine for treating malignancies.
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In cancer cells, the balance of cell death with survival is fre-
quently disturbed by the mutation of oncogenes or tumor
suppressor genes and by the alteration of signaling pathways
[1]. Because perturbation of the cell death process is closely
related to cancer progression and resistance to chemother-
apy or radiotherapy, accumulating evidence has shown that
agents targeting the programmed cell death (PCD) pathway
without affecting normal cells play crucial roles as potential
drug targets in cancer treatment [2]. PCD, a cell suicide pro-
gram, plays pivotal roles in the development, tissue homeo-
stasis, and elimination of damaged cells as a basic biological
phenomenon and can be classified according to morpho-
logical differences as apoptosis (type I), autophagy (type II),
and programmed necrosis (type III) [3,4].
Apoptosis, a major type of cell death that occurs when
DNA damage is unrecoverable, is characterized by distinct
morphological and biochemical changes such as cell shrink-
age, membrane blebbing, chromatin condensation, and
ultimately, fragmentation of cells into membrane-enclosed
vesicles designated as apoptotic bodies, loss of adherence
to extracellular matrix, activation of proteases, and
externalization of phosphatidylserine [5]. Autophagy is a
physiological process that provides energy required for the
turnover of cellular proteins and other macromolecules
under certain stress conditions such as nutrient deprivation,
hypoxia, and metabolic, genotoxic, and oxidative stress.
Autophagy is regarded as a cell survival and protection
mechanism; thus, it may play a negative role in cancer ther-
apy and limit the therapeutic efficacy of chemotherapeutic
agents [6]. However, recent studies have reported that ex-
cessive and sustained autophagy by various anti-cancer
therapies can eventually induce cell death in many kinds of
cancer cells [7-11], supporting the notion that autophagy
may act as either a guardian or an executor. In addition, es-
pecially in apoptosis-defective cells, autophagy triggered by
cytotoxic drugs promotes cancer cell death via excessive en-
gulfment of cytoplasmic cellular components within a vacu-
ole (autophagosome) and delivery to the lysosome for
degradation [12]. In some circumstances, autophagy and
apoptosis occur simultaneously in cancers and may be
interconnected by certain upstream signaling pathways
[13,14]. Among them, the protein kinase B/mammalian tar-
get of rapamycin/p70S6K (Akt/mTOR/p70S6K) signaling
pathway is coordinately regulated in both apoptosis and au-
tophagy, and Beclin-1 is an integrator that regulates apop-
totic and autophagic activities [15].
The autophagy gene Beclin-1, as part of the class III
phosphatidylinositol 3 kinase (PI3K) complexes, partici-
pates in the formation of autophagic vesicles and is critical
in the mediation of localization of other autophagic pro-
teins to pre-autophagosomal membranes. Overexpression
of Beclin-1 in human cervical cancer cells has been
reported to induce massive autophagic cell death andinhibit cancer cell growth [16]. Some anti-apoptotic B-cell
lymphoma 2 (Bcl-2) family members including Bcl-2 and
Bcl-xL can interact with Beclin-1, and the Beclin-1/Bcl-2
complex functions as an inhibitor of autophagy-induced
cell death. Thus, dissociation of Beclin-1 from Bcl-2 is re-
quired for Beclin-1-dependent autophagy induction [17].
Similarly, the constitutively activated class I PI3K/Akt
pathway inhibits both apoptosis and autophagy because it
acts as a positive regulator of the mTOR signaling pathway
and plays a crucial role in cancer cell survival. Thus, dis-
ruption of the class I PI3K/Akt pathway by anti-cancer
agents induces autophagy [18,19].
Samsoeum (SSE, Shensuyin in Chinese, Jinsoin in
Japanese), a traditional herbal medicine, was first described
during the Song Dynasty of China and has been widely used
as a remedy for headache, cough, rhinorrhea, and fever. SSE
also has been used to treat congestion with phlegm, tidal
fever, and emesis. Recent studies have reported the pharma-
cological efficacy of SSE in allergic and asthma reactions
and pulmonary damage from ozone [20]. SSE modulates al-
lergic and inflammatory reactions via inhibition of the ex-
pression of cyclooxygenase 2 (COX-2) and inflammatory
cytokines and suppression of nuclear factor-κB (NF-κB) acti-
vation [21]. However, the anti-cancer effect of SSE and its
exact mechanism of action remain to be examined. There-
fore, the present study aimed to elucidate the effect of SSE
on the cell growth and cell death in cancer cells and investi-
gate the detailed mechanism of its anti-cancer activity.
Methods
Cell lines
The human gastric carcinoma AGS cell line, human fibro-
sarcoma HT1080 cell line, human epidermoid carcinoma
A431 cell line, and murine melanoma B16F10 cell line were
purchased from American Type Culture Collection (ATCC,
Manassas, VA). Each cell line was maintained as a mono-
layer culture in Roswell Park Memorial Institute (RPMI)
1640 or Dulbecco’s Modified Eagle Medium (DMEM;
Lonza, Walkersville, MD) supplemented with 10% (v/v)
heat-inactivated fetal bovine serum (FBS; GIBCO/
Invitrogen, Carlsbad, CA), 100 units/mL penicillin, and
100 μg/mL streptomycin (Welgene) at 37°C in a humidified
5% CO2 incubator. Murine hepatocytes were isolated from
6–8 weeks old female ICR mouse purchased from Nara Bio
animal center (Nara Biotech, Korea). Mice were housed
under standard conditions at a temperature of 24 ± 1°C and
humidity of 55 ± 5%, and experimental procedures were ap-
proved by Korea Institute of Oriental Medicine Care and
Use Committee with a reference number 12–122. Mice
were cared for in accordance with the dictates of the
National Animal Welfare Law of Korea and experiments
were carried out in accordance with the Korea Institute of
Oriental Medicine Care Committee Guidelines. Murine he-
patocytes were isolated using a perfusion system with some
Table 1 The prescription of Samsoeum (SSE)
Herbal name Dose (g) Relative amount (%)
Paerillae Folium 3.75 9.1
Puerariae Radix 3.75 9.1
Pinelliae Tuber 3.75 9.1
Angelicae Decursivae Radix 3.75 9.1
Ginseng Radix 3.75 9.1
Poria Sclerotium 3.75 9.1
Autantii Fructus Immaturus 2.81 6.8
Platycodonis Radix 2.81 6.8
Glycyrrhizae Radix et Rhizoma 2.81 6.8
Citri Unshius Pericarpium 2.81 6.8
Zingiberis Rhizoma Crudus 3.75 9.1
Zizyphi Fructus 3.75 9.1
Total 41.24 100
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medium containing 10% FBS, 100 IU/mL insulin, 2 mM L-
glutamine, 15 mM HEPES, 100 units/mL penicillin, and
100 μg/mL streptomycin, hepatocytes were seeded on the
culture plate coated with 10% gelatin/phosphate buffered sa-
line (PBS), and incubated at 37°C in a humidified 5% CO2
incubator.
Antibodies and reagents
Propidium iodide (PI), Ribonuclease A (RNase A) from bo-
vine pancreas, and 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphe-
nyltetrazolium bromide (MTT) were purchased from Sigma
Chemical Co. (St Louis, MO, USA). Antibodies against
Cyclin D1, Cyclin B1, Cdc25, and α-tubulin were obtained
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).
Anti-p21Waf1/Cip1, anti-p27Kip1, anti-caspase-3, poly (ADP-ri-
bose) polymerase (PARP), anti-p38, anti-phospho-p38
(Thr180/Tyr182), anti-extracellular signal-related kin-
ase1/2 (ERK), anti-phospho-ERK (Thr202/Tyr204),
anti-c-Jun-N-terminal kinase (JNK), anti-phopsho-JNK
(Thr183/Tyr185), anti-Akt, anti-phopho-Akt (Ser473), anti-
mTOR, anti-phospho-mTOR (Ser2481), anti-adenosine
monophosphate activated-activated protein kinase (AMPK),
anti-phospho-AMPK (Thr172), anti-Bcl-2, anti-Bax, and
anti-Beclin-1 antibodies were purchased from Cell Signal-
ing Technology (Danvers, MA, USA). Anti-microtubule-
associated protein light chain 3 (LC3) and anti-cleaved
caspase-3 antibodies were from Sigma Chemical Co. and
Abcam (Cambridge, UK), respectively. All of the other
chemicals and solvents used were analytical grade.
Preparation of herbal extract, Samsoeum (SSE)
Samsoeum (SSE) is composed of 12 Korean medicinal
herbs (Table 1) which were obtained from Yeongcheon
Oriental Herbal Market (Yeongcheon, Korea). Identification
of all herbs was confirmed by Prof. Ki Hwan Bae of the Col-
lege of Pharmacy, Chungnam National University (Daejeon,
Korea), and all voucher specimens were deposited in the
herbal band in Korea Institute of Oriental Medicine
(KIOM, Daejeon, Korea). A decoction of SSE was extracted
in distilled water by heating for 3 h at 115°C in an extractor
(Cosmos-600 Extractor, Gyeonseo Co., Inchon, Korea), fil-
tered using standard testing sieves (150 μm, Retsch, Haan,
Germany), and then concentrated to dryness in a lyophi-
lizer. The freeze-dried SSE extract was dissolved in distilled
water at concentration of 25 mg/mL, filtered through a 0.22
μm disk filter, and then kept at 4°C prior to use.
Cell viability and cell death assay
Cells were seeded at a density of 5 × 103 cells/well in 96-
well culture plates, and then incubated with concentrations
of SSE between 10 to 250 μg/mL. Untreated ‘control’ cells
were incubated with DMSO at final concentration of 0.01%.
After 24 h of treatment, cells were incubated with 10 μL ofMTT solution (5 mg/mL in PBS) for additional 4 h,
formazan precipitates were dissolved by dimethyl sulfoxide
(DMSO) and then absorbance was measured at 570 nm
with Infinite® M200 microplate reader (TECAN Group Ltd.
Switzerland). For cell death evaluation, SSE-treated cells
were stained in 0.4% trypan blue solution (GIBCO) and then
counted using a hemacytometer (Neubauer Improved,
Marienfeld, Germany) under inverted microscope (Olympus
CKX41SF; Olympus Optical Co. LTD, Tokyo, Japan). In the
experiment with inhibitors, cells were treated with indi-
cated concentrations of SSE for 24 h with or without a
1 h pretreatment with 10 μM SP600125 (Calbiochem,
San Diego, CA), 10 μM SB203580 (Calbiochem), 10 μM
PD98059 (Calbiochem), 100 μM 3-methyladenine (3-MA;
Sigma), or 10 μM z-VAD-fmk (Calbiochem).
Cell cycle analysis
Cells were seeded on 60 mm culture dishes at a density of
5 × 105 cells/dish and allowed to adhere overnight. After in-
cubation with 50 μg/mL of SSE for 6, 12, and 24 h, cells were
harvested, washed twice with PBS, and fixed with ice-cold
70% ethanol at −20°C for 24 h. Subsequently, cells were
centrifuged, washed once with PBS, and then intracellular
DNA was labeled with 0.5 mL of cold propidium iodide (PI)
solution (0.1% Triton X-100, 0.1 mM EDTA, 50 μg/mL
RNase A, 50 μg/mL PI in PBS) on ice for 30 min in the dark.
Cell cycle distribution was measured with FACSCalibur flow
cytometry using CellQuest software (BD Biosciences, San
Jose, CA) and analyzed using WinMDI 2.8 software (J. Trot-
ter, Scripps Research Institute, La Jolla, CA).
Detection of YO-PRO-1 uptake and nuclear staining with DAPI
For the detection of apoptosis, cells seeded on 60 mm cul-
ture dishes were treated with 50 μg/mL of SSE for 6, 12,
and 24 h, harvested, and then incubated with apoptosis-
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10 μM for 5 min. YO-PRO-1 uptake was determined with
FACSCalibur flow cytometry using CellQuest software and
analyzed using WinMDI 2.8 software. In addition, SSE-
treated cells (1 × 104 cells/0.2 mL PBS) were spun onto
glass slides by cytospin centrifuge (Cellspin; Hanil, Korea)
at 400 × g for 4 min, fixed with 4% paraformaldehyde for
10 min at 37°C, stained with DAPI solution for 10 min,
and then observed under the fluorescence microscope
(Olympus TH4-200; Olympus Optical Co. LTD).
Fluorescence analysis of LC3 distribution
Cells (5 × 104) grown on the coverslips in 24-well cul-
ture plates were transiently transfected with RFP-LC3
plasmid using TransIT-2020 (Mirus, Madison, WI),
treated with 50 μg/mL SSE for 12 h, and then appear-
ance of RFP-LC3 puncta was visualized on a confocal
laser scanning microscope (FV10i-W; Olympus Optical
Co. LTD) after mounting the coverslips onto glass slides
with Vectashield (mounting medium with DAPI, Vector
Laboratories, Burlingame, CA).
Western blot analysis
After washing cells twice with PBS, whole cell lysates were
extracted in M-PER Mammalian Protein extraction Reagent
(Thermo Scientific, Rockford, IL) by centrifugation (12000 g ×
15 min, 4°C). Equal amount of protein (20–40 μg) was sepa-
rated by electrophoresis on 8-15% SDS-polyacrylamide gels,
and transferred to Immobilon®-P PVDF transfer membrane
(Millipore, Bedford, MA). After immunoblotting, proteins
were visualized using a PowerOpti-ECL Western blottingTable 2 RP-HPLC-DAD operating conditions for analysis
of Samsoeum (SSE)
Item Condition
Instrument Waters 2695 and 966 photodiode array detector
Software system Waters Empower 1.0 software system
Column RS tech C18 column (5 μm, 4.6 mm× 250 mm)
Column temperature 40°C
Injection volume 20 μL
Mobile phase Water with 0.1% trifluoroacetic acid (TFA)(A) and
Acetonitrile (B)
Flow rate 1.0 mL/min
UV wavelength 254 and 280 nm






70 25 75Detection reagent (Animal Gentetics, Inc. Korea) and an
ImageQuant LAS 4000 mini (GE Healthcare, Piscataway, NJ).
Band intensities were quantified using ImageJ software
(National Institutes of Health, USA).
Preparation of standard and sample
The standard solutions of seven components, puerarin,
daidzin, liquiritin, naringin, hesperidin, neohesperidin, and
glycyrrhizin were prepared by dissolving 2 mg of each com-
pound in methanol at the concentration to 200 ppm. The
SSE powder was dissolved in water at the concentration of
50 mg/mL, and then filtered through a 0.45 μm PVDF
membrane filter (ADVANTEC, Japan) before analysis.
Chromatographic conditions
The experiments were carried out using RP-HPLC-DAD
(reverse phase high-performance liquid chromatography-
photoiodide array detector) system consisting of a Waters
2695 Alliance (Milford, MA) separation module and a 966
photodiode array detector. The output signal of the detector
was recorded using Waters Empower 1.0 software system.
The chromatographic separation was conducted with RS-
tech C18 column (Optomapak C18, 4.6 × 250 mm, 5 μm,
Daejeon, Korea), the column oven temperature was kept at
40°C, and the injection volume was 20 μL. The wavelength
of the UV detector was set at 254 nm and 280 nm. The mo-
bile phase composed of water containing 0.1% trifluoroacetic
acid (TFA, A) and acetonitrile (B). The run time was
70 min, the flow rate of the mobile phase was 1.0 mL/min,
and the mobile phase program was the gradient elution as
follows; 5% B (0–10 min) and 5-15% B (10–15 min), 15-20%
B (15–35 min), 20-25% B (35–45 min), and 25-75% B (45–
70 min). Chromatographic conditions were summarized in
Table 2.
Statistical analysis
Data are presented as the mean ± S.D. values of at least
3 independent experiments, unless otherwise specified.
Statistical significance was analyzed by the two-tailed
Student’s t-test in Sigma Plot 8.0 software (SPSS Inc.,
Chicago, IL) and a P value of less than 0.05 was consid-
ered statistically significant.
Results and discussion
SSE treatment induces concentration- and time-dependent
cell death and G2/M arrest in cancer cells
To investigate the anti-cancer effect of SSE, we treated sev-
eral human and murine cancer cell lines, including HT1080,
AGS, A431, and B16F10, with various concentrations of SSE
(10, 25, 50, 100, and 250 μg/mL) for 24 h and assessed cell
viability and cell death using MTTassay and trypan blue ex-
clusion assay, respectively. As shown in Figure 1A and 1B,
SSE reduced cell viability and caused cell death in propor-
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Figure 1 SSE induces dose- and time-dependent cell death in human and murine cancer cell lines. (A) Cells seeded on 96-well plates (5 × 103
cells/well) were treated with the indicated concentrations of SSE for 24 h, and the relative cell viability was assessed using MTT assay. (B) After incubation of cells
with the indicated concentrations of SSE, dead cells were counted using trypan blue exclusion assay. The data represent 3 independent experiments carried out
in triplicate and expressed as mean ± SD. (C) AGS, B16F10, and murine hepatocytes were incubated with 25 and 50 μg/mL of SSE during the indicated periods
and then observed under an inverted microscope.



























































































7.3 7.91 8.7 13.9
8.4 8.61 9.3 17.0
0.5 0.31 0.1 0.2
1.4 0.71 0.4 0.3
0.6 1.01 0.5 1.1
3.4 4.31 4.7 6.7
1.4 2.31 2.4 5.5
0.2 0.21 0.1 0.1
0.8 0.61 0.7 0.2












Figure 2 SSE arrests cell cycle progression at G2/M phase. AGS (A) and B16F10 (B) cells were treated with 50 μg/mL SSE for the indicated
incubation times (6, 12, and 24 h), fixed with ice-cold 70% ethanol, and stained with propidium iodide solution and then subjected to flow cytometry for
the determination of cell cycle distribution. Expression of cell cycle-related proteins was examined with western blot analysis in SSE-treated AGS (C) and
B16F10 (D) cells. The amount of α-tubulin served as the protein loading control, and relative band intensity compared to untreated “control” cells was
calculated using ImageJ after normalization to α-tubulin expression. The data represent 3 independent experiments.
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(HT1080, IC50 = 25.1 μg/mL; AGS, IC50 = 42.1 μg/mL;
A431, IC50 = 344.8 μg/mL; B16F10, IC50 = 388.9 μg/mL). Of
these cell lines, human gastric carcinoma AGS and murine
melanoma B16F10 cell lines were used in all subsequent ex-
periments. Under a phase contrast microscope, viable AGS
and B16F10 cells were significantly decreased by SSE treat-
ment in a time- and dose-dependent manner, and the ma-
jority of cells shrank and became rounded before detaching
from the culture plates (Figure 1C), a typical morphologic
appearance in apoptotic cell death. In addition, SSE-treated
cancer cells developed a highly granular appearance. Some
herbal remedies and dietary supplements have been
reported to induce hepatotoxicity because the liver plays an
essential role in transforming and clearing chemicals [23].Therefore, we next examined the effect of SSE on the cell
viability of normal hepatocytes. As shown in Figure 1C, nor-
mal hepatocytes were unaffected by SSE treatment even
after incubation for 48 h at 50 μg/mL, suggesting that SSE is
cytotoxic to cancer, but not to normal hepatocytes.
For further determination of the potential role of SSE
in modulating cell cycle progression, cells were treated
with 50 μg/mL SSE for 6, 12, and 24 h, and then the cell
cycle distribution was analyzed with PI staining and flow
cytometry. In AGS cells, SSE treatment for 6 and 12 h
increased the proportion of cells in G2/M phase to
31.19% and 41.57%, respectively (Figure 2A) compared
with that in untreated cells (20.34%). An increase in cell
cycle arrest in G2/M phase was also detected in B16F10
cells at 6 and 12 h post-SSE treatment (36.31% and
AYo-PRO-1 uptake
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Figure 3 SSE induces both apoptotic and autophagic cell death. (A) AGS cells were treated with SSE (25 and 50 μg/mL) for 6, 12, and 24 h,
stained with YO-PRO-1, and analyzed using flow cytometry. Histogram and density plot data are shown. (B) For the detection of chromatin condensation,
cells treated with SSE (50 μg/mL) for 24 h were stained with DAPI and observed under a fluorescent microscope. (C) Cells seeded on cover slips were
transiently transfected with RFP-tagged LC3 plasmid DNA (RFP-LC3), treated with SSE (50 μg/m) for 12 h, and observed for fluorescence. (D) Caspase-3
activation, PARP cleavage, increases in Beclin-1, and LC3-II expression were assessed using western blot analysis after treatment with SSE (25 and 50 μg/mL)
for 12 and 24 h. Changes in Bcl-2 and Bax expression after SSE treatment were also determined. Data represent 3 independent experiments.
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increase was accompanied by a corresponding decrease
in the proportion of cells in S phase and G0/G1 phase.
Furthermore, 24-h post-SSE treatment, the apoptotic
sub-G0/G1 peak was considerably increased to 35.56%
and 55.05% in AGS and B16F10 cells, respectively, indi-
cating that G2/M cell cycle arrest by SSE inhibited
growth and consequently induced cell death. Consistent
with this observation, SSE treatment elevated levels of
cyclin-dependent kinase inhibitors p21 and p27 after 6 h
of treatment and longer and reduced levels of cyclin D1,
cyclin B1, and cdc25 in AGS (Figure 2C) and B16F10
(Figure 2D) cells in a dose- and time-dependent manner
compared with those in untreated control cells.
SSE induces both apoptosis and autophagy in AGS and
B16F10 cells
To analyze whether SSE induces apoptosis or autophagy, we
initially assessed the extent of YO-PRO-1 uptake using flow
cytometry in AGS cells undergoing SSE-induced cell death.
Permeability to YO-PRO-1 is an early event in apoptotic cell
death and occurs well before the loss of membrane integrity
[24]. Accordingly, YO-PRO-1 uptake was considerably in-
creased to 17.71% and 29.31% even after 6 h treatment atconcentrations of 25 and 50 μg/mL, respectively, compared
with that of control cells (10.37%), and further accumulation
occurred in proportion to incubation time and concentration
(Figure 3A). SSE treatment for 24 h at 50 μg/mL resulted in
an approximately 5.2-fold (53.57%) increase in the apoptotic
rate (10.37% for control). After DAPI staining, AGS and
B16F10 cells treated with SSE (50 μg/mL) for 24 h exhibited
chromatin condensation (Figure 3B, white arrows). Next, to
determine whether SSE induces autophagy, we examined the
intracellular distribution of LC3, an autophagy marker, in re-
sponse to SSE treatment in AGS and B16F10 cells transfected
with an expression construct for LC3 fused to red fluorescent
protein (RFP-LC3) under a confocal microscope. As shown
in Figure 3C, in AGS cells, RFP-LC3 was evenly diffused
throughout the cytoplasm in control cells, whereas SSE-
treated cells displayed a punctuate pattern of RFP-LC3 fluor-
escence, indicating the association of RFP-LC3 with the
autophagosomal membrane. In B16F10 cells, SSE treatment
remarkably increased punctuate pattern of RFP-LC3 fluores-
cence. LC3, the mammalian equivalent of yeast Atg8, is
cleaved from LC3-I (18 kDa) to LC3-II (16 kDa) during
autophagy via proteolytic cleavage and lipidation, and this
modification of LC3 is essential for the formation of
autophagosomes and completion of autophagy [25]. LC3-I
α-tubulin
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t-AMPK
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Figure 4 SSE inhibits Akt/mTOR pathway and activates MAPKs pathway. (A) Cell lysates were prepared after treatment with SSE at 50 μg/mL
for 0.25, 0.5, 1, 3, and 6 h, and then subjected to western blot analysis for the determination of levels of AMPK, Akt, mTOR, and their phosphorylated
forms. (B) Lysates were also determined for the levels of p38, ERK, JNK, and phosphorylated forms. Data represent 2 independent experiments.
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membranes, respectively; thus, the redistribution of LC3 in
autophagosomal membranes as observed in Figure 3C may
be strong evidence for autophagy induction.
To gain further insight into the mechanism by which
SSE induces cell death, we examined the effect of
SSE treatment on the expression of apoptosis- and
autophagy-related proteins using western blot analysis
(Figure 3D). The protein levels of Beclin-1, which initi-
ates autophagosome formation during autophagy, were
gradually increased in AGS and B16F10 cells after SSE
treatment. Moreover, the ratio of LC3-II to LC3-I was
significantly increased in SSE-treated AGS and B16F10cells. In addition, SSE treatment significantly inhibited
anti-apoptotic Bcl-2 expression, enhanced pro-apoptotic
Bax expression, and resulted in the cleavage of caspase-
3 and PARP, a downstream target of activated caspase-3.
Bcl-2 family proteins including Bcl-2 and Bcl-xL are fre-
quently overexpressed in cancers and inhibit apoptosis
by binding to Bax or Bak [26]. Moreover, Bcl-2 and Bcl-
xL suppress autophagy by binding to the BH3 domain
(amino acids 114–223) of the Beclin-1 protein and seques-
tering Beclin-1 from hVps34, which is a significant regula-
tor in the initial steps of autophagy, indicating that Bcl-2
and Bcl-xL play essential roles in the crosstalk between
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Figure 5 JNK activation is required for the up-regulation of Beclin-1 and subsequent cell death by SSE. (A) After pre-incubation with
specific inhibitors including SP600125 (10 μM), SB203580 (10 μM), PD98059 (10 μM), or 3-MA (100 μM) for 1 h, B16F10 cells were treated with SSE at 50
μg/mL for 24 h and then observed under phase contrast microscope. (B) The effect of specific MAPK inhibitors on the expression of Beclin-1, LC3-I/-II,
Bcl-2, and Bax was evaluated. Cell lysates were prepared after incubation for 12 h with specific inhibitors for 1 h before SSE treatment. (C) After
pre-incubation with or without specific inhibitors, cells were treated with 50 μg/mL SSE for 24 h, and cell viability was determined using MTT assay.
Data acquired from 2 independent experiments are expressed as mean ± SD. *p < 0.05 versus control, **p < 0.05 versus SSE-treated cells.
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tosis, which partner to induce cell death cooperatively by
modifying Beclin-1 and Bcl-2 expression.
SSE suppresses the PI3K/Akt/mTOR pathway via
activation of AMPK and activates the mitogen-activated
protein kinase (MAPK) pathway
The PI3K/Akt/mTOR signaling pathway is frequently acti-
vated in human cancers, and it modulates cancer cell pro-
liferation, metastasis, and acquired drug resistance.
Activation of class I PI3K inhibits apoptosis and autophagy
through activation of Akt and mTOR [28]. Beclin-1 expres-
sion and Akt/mTOR pathway inhibition are consistentlyconnected with the induction of autophagy in cancer cells
[27,29]. Previous studies have demonstrated that autophagy
is regulated by multiple signaling pathways, including class
III PI3K, class I PI3K/Akt/mTOR, and MAPKs. To deter-
mine whether SSE-induced cell death involves the PI3K/
Akt/mTOR signaling pathway, we measured the phosphor-
ylation status of Akt at Ser473, mTOR at Ser2481, and
AMPK, a repressor of mTOR, at Thr172 in SSE-treated
AGS and B16F10 cells using western blot analysis. As
shown in Figure 4A, treatment of AGS and B16F10 cells
with 50 μg/mL SSE significantly increased AMPK phos-
phorylation and reduced Akt and mTOR phosphorylation.
A recent study has shown that JNK activation during
1. Puerarin 2. Daidzin 3. Liquiritin
4. Naringin 5. Hesperidin
6. Neohesperidin 7. Glycyrrhizin
Figure 6 Chemical structures of 7 standard compounds in SSE.
Kim et al. BMC Complementary and Alternative Medicine 2013, 13:233 Page 10 of 14
http://www.biomedcentral.com/1472-6882/13/233nutrient starvation induces Bcl-2 phosphorylation and
Beclin-1 expression, eventually promoting apoptosis and
autophagy by dissociating Bcl-2 from Bax and disrupting
the Bcl-2-Beclin-1 complex, respectively [30]. Additionally,
sustained activation of mitogen-activated protein kinase/
extracellular signal-regulated kinase (ERK) downstream of
AMPK reportedly leads to a marked increase in Beclin-1
expression [31], and ER stress-induced Beclin-1 expression
and autophagy induction correlate with increased p38 acti-
vation. In our study, SSE treatment significantly increased
phosphorylation of p38, ERK, and JNK (Figure 4B). In
AGS cells, MAPK phosphorylation peaked 30 min after
SSE treatment, whereas this peak was reached at 6 h in
B16F10 cells. Taken together, these results demonstrate
that SSE induces cell death by inhibiting Akt and mTOR
activity and by activating the MAPK pathway.
JNK activation is required for the up-regulation of Beclin-1,
LC3-II, and Bax and down-regulation of Bcl-2 expression in
response to SSE
To investigate further the role of MAPK activation in SSE-
mediated cell death, we pre-incubated cells with or withoutpharmacological inhibitors of JNK (SP600125, 10 μM), p38
(SB203580, 10 μM), or ERK (PD98059, 10 μM) for 1 h,
followed by SSE treatment for 24 h. As shown in Figure 5A,
cells treated with SSE showed morphological features of
cytoplasmic vacuole accumulation and only pre-incubation
with SP600125 nearly blocked vacuole formation in a man-
ner similar to 3-MA, an inhibitor for autophagosome for-
mation. Immunoblot analysis showed that pre-incubation
with SP600125 completely prevented the induction of
Beclin-1, LC3-II, and Bax and reduction of Bcl-2 by SSE
treatment to the extent observed in untreated control cells,
whereas pre-incubation with SB203580 and PD98059
showed partial or few inhibitory effects compared to that
of SP600125 (Figure 5B). SP600125 also significantly
protected SSE-treated cells from cell death by about 80%,
whereas SB203580 showed a partial effect of approximately
50%, and PD98059 had little effect (Figure 5C). Moreover,
pre-incubation with z-VAD-fmk, a pan-caspase inhibitor,
showed a partial inhibitory effect. Collectively, these data
indicate that SSE-mediated cell death is mainly contributed
by JNK activation, followed by modification of autophagy-











































































Figure 7 RP-HPLC-DAD chromatograms of 7 major compounds. puerarin (1), daidzin (2), liquiritin (3), naringin (4), hesperidin (5), neohesperidin
(6), and glycyrrhizin (7) in the standard mixture (A) and SSE sample (B) identified at wavelengths of 254 and 280 nm.

























Figure 8 Schematic diagrams showing the mechanisms underlying anti-cancer effects of SSE.
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RP-HPLC-DAD system
HPLC analysis was performed for the identification of 7 main
components in SSE, including puerarin, daidzin, liquiritin,
naringin, hesperidin, neohesperidin, and glycyrrhizin
(Figure 6). A C18 column was used for analysis, and the flow
rate of the mobile phase was fixed at 1.0 mL/min. To achieve
the desired separation, we tested the gradient elution propor-
tions of water and acetonitrile. Trifluoroacetic acid was
added to water to advance a peak shape and inhibit peak tail-
ing. The ultraviolet (UV) wavelength of the 7 components
was adjusted based on the maximum UV spectra absorption
of each component. As shown in Figure 7A, puerarin,
daidzin, and glycyrrhizin were detected at 254 nm, and
liquiritin, naringin, hesperidin, and neohesperidin were
detected at 280 nm. Each component in SSE was character-
ized by comparing retention time and UV spectra. The pro-
files of puerarin (1, tR: 21.10 min), daidzin (2, tR: 24.82 min),
liquiritin (3, tR: 29.62 min), naringin (4, tR: 37.28 min),
hesperidin (5, tR: 39.75 min), neohesperidin (6, tR:
42.17 min), and glycyrrhizin (7, tR: 58.97 min) were
identified in the SSE samples (Figure 7B). A previous
study has reported that hesperidin decreases Bcl-2 ex-
pression and increases Bax and active caspase-3 expres-
sion, resulting in apoptotic cell death in human colon
cancer cells [32]. Puerarin has an apoptotic effect in
colon cancer via caspase-3 activation and Bcl-2 down-
regulation [33]. A recent study has reported that
naringin induces Fas death receptor- and mitochondria-
mediated apoptosis in human cervical carcinoma and
SiHa cells [34] and causes G1 cell cycle arrest via up-
regulation of p21 via activation of the Ras/Raf/ERKpathway in urinary bladder carcinoma 5637 cells [35].
Other reports have demonstrated that glycyrrhizin ex-
hibits potent cytotoxic effects against human prostate can-
cer cells LNCaP and DU145 via caspase-3 and caspase-8
activation [36]. These facts suggest that the anti-cancer ac-
tivity of SSE might be related to these active components.
Because advanced malignancies require treatment
targeting multiple cellular pathways, properly formulated
herbal cocktails are believed to take advantage of synergy
and achieve better therapeutic efficacy than that of a sin-
gle herb. In the present study, we found that both apop-
tosis and autophagy contribute to cancer cell death
induced by SSE, a traditional herbal formula, in a com-
plementary and cooperative fashion by regulating key
signaling pathways upstream of these 2 processes. Our
data revealed that SSE efficiently inhibits the growth of
and causes death in several cancer cell lines, including
AGS and B16F10 cells, which are commonly associated
with G2/M cell cycle arrest, regulation of anti-apoptotic
and pro-apoptotic proteins, activation of caspase-3, in-
crease of Beclin-1, and conversion of LC3-I to LC3-II.
Disruption of the PI3/Akt pathway culminating in Akt
inactivation reportedly plays a critical role in apoptosis
as well as autophagy induction. Additionally, Bcl-2 regu-
lates PI3K/Akt signaling, in turn positively regulating the
mTOR signaling pathway, which can inhibit autophagy in-
duction; it also down-regulates Beclin-1-dependent au-
tophagy by interacting with Beclin-1 or by inhibiting the
formation of the Beclin-1-hVps34 PI3K complex, which
can enhance autophagy (Figure 8) [17,27]. The relation-
ship between these types of PCD is still controversial be-
cause they may cooperate, coexist, or antagonize each
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ments using pharmacological inhibitors demonstrated that
SSE treatment displayed collaborative interplay between
apoptosis and autophagy for cell death.
Conclusions
In summary, our finding clearly demonstrated that SSE
has anti-cancer activity via suppression of the Akt/
mTOR signaling pathway through AMPK activation,
which resulted in the down-regulation of Bcl-2 and up-
regulation of Beclin-1. SSE treatment activated MAPKs
including p38, ERK, and JNK; however, only SP600125, a
specific inhibitor for JNK activation, nearly prevented
SSE-induced cell death by blocking changes in the level
of key proteins such as Bcl-2, Bax, Beclin-1, and LC3-II.
In particular, SSE causes both apoptosis and autophagy,
and these PCD processes are indispensable for the in-
duction of cell death. Collectively, these results provide
new insight into the pharmacological action of SSE as a
potent herbal medicine for the treatment of malignant
tumors.
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